SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $33,000 | +106.2% | 297 | +43.5% | 0.01% | +150.0% |
| Q2 2022 | $16,000 | 0.0% | 207 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $16,000 | -33.3% | 207 | -21.6% | 0.00% | -33.3% |
| Q4 2021 | $24,000 | -25.0% | 264 | -25.4% | 0.00% | -25.0% |
| Q3 2021 | $32,000 | +18.5% | 354 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $27,000 | -3.6% | 354 | -8.3% | 0.00% | 0.0% |
| Q1 2021 | $28,000 | -60.6% | 386 | -7.4% | 0.00% | -63.6% |
| Q4 2020 | $71,000 | – | 417 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |